CXCL13–Fc and CXCR5-Engineered CD8⁺ T Cells
Project overview
We are investigating how CXCL13–Fc affects the trafficking and antitumor function of CXCR5-engineered CD8⁺ T cells.
Role: Core contributor
Supervisor:
Suzhou Institute of Systems Medicine
Chinese Academy of Medical Sciences & Peking Union Medical College
Jan 2026–Present